Close

Roth Capital Remains Positive on Actinium Pharma (ATNM) as Iomab-B Gains Orphan Designation in Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. GM
3. SPY
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. IBM
9. NVDA
10. MTTR


Go back to Roth Capital Remains Positive on Actinium Pharma (ATNM) as Iomab-B Gains Orphan Designation in Europe